Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
Classificação em ações #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
Preço da ação
$0.00733708
Última sincronização: 2026-04-23
Valor de mercado
$273.87K
Variação (1 dia)
-39.13%
Variação (1 ano)
-94.83%
País
NO
Negociar PCI Biotech Holding ASA (PCIB)

Categoria

Histórico de preços das ações de PCI Biotech Holding ASA (PCIB)
Preço de fecho mais alto: $0.02 em 2026-04-01

Preço de fecho mais baixo: $1.50 em 2008-06-01
Histórico de preços das ações da PCI Biotech Holding ASA de 2008 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -3.83%
2025 -79.63%
2024 -36.96%
2023 -11.71%
2022 -84.13%
2021 -54.32%
2020 -59.39%
2019 143.06%
2018 1.83%
2017 93.21%
2016 351.92%
2015 -72.20%
2014 -40.12%
2013 -37.49%
2012 -10.04%
2011 -12.25%
2010 321.24%
2009 32.65%
2008 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.15%
KR
$259.89 14.81%
BE